breast cancer cells - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

NeoTX commences dosing in Phase Ib trial of naptumomab

breast cancer cells
The Phase Ib trial will investigate naptumomab plus Imfinzi for treating advanced or metastatic solid tumours. Credit: Dr. Cecil Fox, National Cancer Institute, National Institutes of Health.